Pharmaceutical Excipients Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, Material Type, Process, End User, Functionality

Description

The global Pharmaceutical Excipients Market is projected to grow from $3.9 billion in 2025 to $6.5 billion by 2035, at a compound annual growth rate (CAGR) of 5.3%. The pharmaceutical excipients market is supported by the rising production of medicines, increasing adoption of complex formulations, and growing demand for functional ingredients in oral, injectable, and biologic drug products. According to the U.S. FDA Inactive Ingredient Database (IID), updated in 2025, the database contains thousands of inactive ingredients that have been used in FDA-approved drug products, highlighting the extensive role of excipients in pharmaceutical development. Increasing innovation in modified-release, pediatric, and targeted drug delivery formulations is further driving demand for advanced excipients.

The Type segment of the Pharmaceutical Excipients Market includes binders, diluents, disintegrants, lubricants, coating agents, flavoring agents, preservatives, colorants, solvents, and others. Among these, binders, diluents, and disintegrants account for significant market shares due to their essential role in tablet and capsule formulation, improving drug stability, compressibility, and bioavailability. Coating agents are gaining importance as they enable controlled drug release, protect active ingredients, and enhance product appearance. Solvents, preservatives, and flavoring agents are also witnessing steady demand due to their increasing use in liquid formulations and patient-friendly drug delivery systems. Advancements in formulation technologies and growing demand for complex drug products are further driving innovation in excipient development.

Market Segmentation
Type	Binders, Diluents, Disintegrants, Lubricants, Coating Agents, Flavoring Agents, Preservatives, Colorants, Solvents, Others
Product	Organic Chemicals, Inorganic Chemicals, Others
Technology	Nanotechnology, Microencapsulation, Others
Application	Oral Formulations, Topical Formulations, Parenteral Formulations, Others
Form	Solid, Liquid, Semi-Solid, Others
Material Type	Polymers, Sugars, Minerals, Gelatin, Others
Process	Granulation, Direct Compression, Others
End User	Pharmaceutical Manufacturers, Biopharmaceutical Companies, Contract Manufacturing Organizations, Others
Functionality	Controlled Release, Immediate Release, Sustained Release, Others

The Application segment of the Pharmaceutical Excipients Market includes oral formulations, topical formulations, parenteral formulations, and others. Oral formulations represent the largest application segment due to their widespread adoption, convenience, patient compliance, and cost-effectiveness. The increasing production of tablets, capsules, and oral solid dosage forms is driving demand for functional excipients. Parenteral formulations are experiencing significant growth due to rising demand for biologics, vaccines, and injectable therapies requiring high-quality excipients for stability and safety. Topical formulations are also expanding with increasing applications in dermatology, wound care, and targeted drug delivery. Growing pharmaceutical manufacturing activities globally are supporting market expansion across all application areas.

Geographical Overview

North America held the largest share of the global pharmaceutical excipients market in 2025, driven by its well-established pharmaceutical manufacturing industry, advanced drug formulation capabilities, and strong demand for innovative drug delivery systems. The region is home to leading pharmaceutical companies and excipient manufacturers that continually invest in the development of multifunctional excipients for tablets, capsules, injectables, and biologics. Increasing production of generic drugs, growing adoption of biologics and specialty medicines, and stringent regulatory standards for pharmaceutical quality have further supported market growth. Additionally, continuous investments in research and development, coupled with the rising use of novel excipients to enhance drug stability, bioavailability, and patient compliance, reinforce North America's leading position in the global pharmaceutical excipients market.

Asia Pacific is expected to register the highest growth in the pharmaceutical excipients market due to rapid expansion of pharmaceutical manufacturing, increasing production of generic medicines, and rising investments in healthcare infrastructure. Countries such as China and India have emerged as major global hubs for pharmaceutical production and active pharmaceutical ingredients (APIs), creating significant demand for high-quality excipients. Meanwhile, Japan and South Korea continue to advance the development of innovative drug formulations and biologics. Growing pharmaceutical exports, favorable government initiatives supporting domestic manufacturing, expanding contract manufacturing activities, and increasing demand for oral solid dosage forms and injectable drugs are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.

Key Trends and Drivers

Growing Adoption of Functional and Novel Pharmaceutical Excipients:

The Pharmaceutical Excipients Market is witnessing a strong trend toward the development and adoption of multifunctional and novel excipients that enhance drug stability, bioavailability, controlled release, and patient compliance. Pharmaceutical manufacturers are increasingly focusing on advanced excipients such as solubilizers, lipid-based carriers, and specialized polymers to support complex drug formulations, including biologics, poorly soluble drugs, and targeted delivery systems. The growth of innovative dosage forms such as orally disintegrating tablets, sustained-release formulations, and injectable therapies is further increasing demand for high-performance excipients. Additionally, regulatory emphasis on excipient safety and quality is encouraging manufacturers to invest in advanced formulation technologies.

Increasing Production of Generic Drugs and Pharmaceutical Formulations:

The growing production of generic drugs, specialty medicines, and advanced pharmaceutical formulations is a major driver of the Pharmaceutical Excipients Market. Rising healthcare demand, patent expirations of branded drugs, and cost-containment efforts by healthcare systems are encouraging pharmaceutical companies to expand generic drug manufacturing, increasing the need for high-quality excipients. Furthermore, the rapid growth of biologics, nutraceuticals, and novel drug delivery systems is creating demand for specialized formulation ingredients that improve drug performance and stability. Expanding pharmaceutical manufacturing capabilities in emerging economies, along with increasing investments in research and development activities, is further supporting the growth of the excipients market globally.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS20190

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Form
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by Material Type
2.6 Key Market Highlights by End User
2.7 Key Market Highlights by Functionality
2.8 Key Market Highlights by Process
2.9 Key Market Highlights by Technology

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Binders
- 4.1.2 Diluents
- 4.1.3 Disintegrants
- 4.1.4 Lubricants
- 4.1.5 Coating Agents
- 4.1.6 Flavoring Agents
- 4.1.7 Preservatives
- 4.1.8 Colorants
- 4.1.9 Solvents
- 4.1.10 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Organic Chemicals
- 4.2.2 Inorganic Chemicals
- 4.2.3 Others
4.3 Market Size & Forecast by Form (2020-2035)
- 4.3.1 Solid
- 4.3.2 Liquid
- 4.3.3 Semi-Solid
- 4.3.4 Others
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Oral Formulations
- 4.4.2 Topical Formulations
- 4.4.3 Parenteral Formulations
- 4.4.4 Others
4.5 Market Size & Forecast by Material Type (2020-2035)
- 4.5.1 Polymers
- 4.5.2 Sugars
- 4.5.3 Minerals
- 4.5.4 Gelatin
- 4.5.5 Others
4.6 Market Size & Forecast by End User (2020-2035)
- 4.6.1 Pharmaceutical Manufacturers
- 4.6.2 Biopharmaceutical Companies
- 4.6.3 Contract Manufacturing Organizations
- 4.6.4 Others
4.7 Market Size & Forecast by Functionality (2020-2035)
- 4.7.1 Controlled Release
- 4.7.2 Immediate Release
- 4.7.3 Sustained Release
- 4.7.4 Others
4.8 Market Size & Forecast by Process (2020-2035)
- 4.8.1 Granulation
- 4.8.2 Direct Compression
- 4.8.3 Others
4.9 Market Size & Forecast by Technology (2020-2035)
- 4.9.1 Nanotechnology
- 4.9.2 Microencapsulation
- 4.9.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Form
  - 5.2.1.4 Application
  - 5.2.1.5 Material Type
  - 5.2.1.6 End User
  - 5.2.1.7 Functionality
  - 5.2.1.8 Process
  - 5.2.1.9 Technology
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Form
  - 5.2.2.4 Application
  - 5.2.2.5 Material Type
  - 5.2.2.6 End User
  - 5.2.2.7 Functionality
  - 5.2.2.8 Process
  - 5.2.2.9 Technology
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Form
  - 5.2.3.4 Application
  - 5.2.3.5 Material Type
  - 5.2.3.6 End User
  - 5.2.3.7 Functionality
  - 5.2.3.8 Process
  - 5.2.3.9 Technology
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Form
  - 5.3.1.4 Application
  - 5.3.1.5 Material Type
  - 5.3.1.6 End User
  - 5.3.1.7 Functionality
  - 5.3.1.8 Process
  - 5.3.1.9 Technology
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Form
  - 5.3.2.4 Application
  - 5.3.2.5 Material Type
  - 5.3.2.6 End User
  - 5.3.2.7 Functionality
  - 5.3.2.8 Process
  - 5.3.2.9 Technology
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Form
  - 5.3.3.4 Application
  - 5.3.3.5 Material Type
  - 5.3.3.6 End User
  - 5.3.3.7 Functionality
  - 5.3.3.8 Process
  - 5.3.3.9 Technology
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Form
  - 5.4.1.4 Application
  - 5.4.1.5 Material Type
  - 5.4.1.6 End User
  - 5.4.1.7 Functionality
  - 5.4.1.8 Process
  - 5.4.1.9 Technology
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Form
  - 5.4.2.4 Application
  - 5.4.2.5 Material Type
  - 5.4.2.6 End User
  - 5.4.2.7 Functionality
  - 5.4.2.8 Process
  - 5.4.2.9 Technology
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Form
  - 5.4.3.4 Application
  - 5.4.3.5 Material Type
  - 5.4.3.6 End User
  - 5.4.3.7 Functionality
  - 5.4.3.8 Process
  - 5.4.3.9 Technology
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Form
  - 5.4.4.4 Application
  - 5.4.4.5 Material Type
  - 5.4.4.6 End User
  - 5.4.4.7 Functionality
  - 5.4.4.8 Process
  - 5.4.4.9 Technology
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Form
  - 5.4.5.4 Application
  - 5.4.5.5 Material Type
  - 5.4.5.6 End User
  - 5.4.5.7 Functionality
  - 5.4.5.8 Process
  - 5.4.5.9 Technology
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Form
  - 5.4.6.4 Application
  - 5.4.6.5 Material Type
  - 5.4.6.6 End User
  - 5.4.6.7 Functionality
  - 5.4.6.8 Process
  - 5.4.6.9 Technology
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Form
  - 5.4.7.4 Application
  - 5.4.7.5 Material Type
  - 5.4.7.6 End User
  - 5.4.7.7 Functionality
  - 5.4.7.8 Process
  - 5.4.7.9 Technology
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Form
  - 5.5.1.4 Application
  - 5.5.1.5 Material Type
  - 5.5.1.6 End User
  - 5.5.1.7 Functionality
  - 5.5.1.8 Process
  - 5.5.1.9 Technology
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Form
  - 5.5.2.4 Application
  - 5.5.2.5 Material Type
  - 5.5.2.6 End User
  - 5.5.2.7 Functionality
  - 5.5.2.8 Process
  - 5.5.2.9 Technology
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Form
  - 5.5.3.4 Application
  - 5.5.3.5 Material Type
  - 5.5.3.6 End User
  - 5.5.3.7 Functionality
  - 5.5.3.8 Process
  - 5.5.3.9 Technology
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Form
  - 5.5.4.4 Application
  - 5.5.4.5 Material Type
  - 5.5.4.6 End User
  - 5.5.4.7 Functionality
  - 5.5.4.8 Process
  - 5.5.4.9 Technology
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Form
  - 5.5.5.4 Application
  - 5.5.5.5 Material Type
  - 5.5.5.6 End User
  - 5.5.5.7 Functionality
  - 5.5.5.8 Process
  - 5.5.5.9 Technology
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Form
  - 5.5.6.4 Application
  - 5.5.6.5 Material Type
  - 5.5.6.6 End User
  - 5.5.6.7 Functionality
  - 5.5.6.8 Process
  - 5.5.6.9 Technology
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Form
  - 5.6.1.4 Application
  - 5.6.1.5 Material Type
  - 5.6.1.6 End User
  - 5.6.1.7 Functionality
  - 5.6.1.8 Process
  - 5.6.1.9 Technology
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Form
  - 5.6.2.4 Application
  - 5.6.2.5 Material Type
  - 5.6.2.6 End User
  - 5.6.2.7 Functionality
  - 5.6.2.8 Process
  - 5.6.2.9 Technology
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Form
  - 5.6.3.4 Application
  - 5.6.3.5 Material Type
  - 5.6.3.6 End User
  - 5.6.3.7 Functionality
  - 5.6.3.8 Process
  - 5.6.3.9 Technology
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Form
  - 5.6.4.4 Application
  - 5.6.4.5 Material Type
  - 5.6.4.6 End User
  - 5.6.4.7 Functionality
  - 5.6.4.8 Process
  - 5.6.4.9 Technology
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Form
  - 5.6.5.4 Application
  - 5.6.5.5 Material Type
  - 5.6.5.6 End User
  - 5.6.5.7 Functionality
  - 5.6.5.8 Process
  - 5.6.5.9 Technology

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 BASF
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Dow Chemical
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Ashland Global Holdings
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Evonik Industries
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 DuPont
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Roquette Freres
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Kerry Group
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Colorcon
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Croda International
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 FMC Corporation
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 JRS Pharma
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Merck KGaA
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Eastman Chemical Company
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Lubrizol Corporation
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Wacker Chemie AG
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Archer Daniels Midland Company
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Associated British Foods
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Cargill
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Avantor
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Ingredion Incorporated
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us